Last reviewed · How we verify
Placebo + relaxation
Placebo + relaxation is a Small molecule drug developed by University of Göttingen. It is currently FDA-approved for Stress-related conditions and anxiety (research/marketed context).
Placebo combined with relaxation techniques produces therapeutic benefit through psychosomatic and mind-body pathways rather than pharmacological action.
Placebo combined with relaxation techniques produces therapeutic benefit through psychosomatic and mind-body pathways rather than pharmacological action. Used for Stress-related conditions and anxiety (research/marketed context).
At a glance
| Generic name | Placebo + relaxation |
|---|---|
| Sponsor | University of Göttingen |
| Modality | Small molecule |
| Therapeutic area | Psychiatry/Psychology, Pain Management, Stress-related disorders |
| Phase | FDA-approved |
Mechanism of action
This intervention leverages the placebo effect—where expectation of benefit triggers neurobiological responses including endorphin release and autonomic nervous system modulation—combined with relaxation-induced parasympathetic activation. The relaxation component reduces sympathetic tone, lowers cortisol, and promotes psychological well-being. Together, these non-pharmacological mechanisms can produce measurable clinical improvements in subjective symptoms and stress-related conditions.
Approved indications
- Stress-related conditions and anxiety (research/marketed context)
Common side effects
- Minimal adverse events expected from placebo and relaxation alone
Key clinical trials
- Effects of Feel Free® Classic Tonic on Stress and Pharmacokinetics in Healthy Adults (NA)
- Use of Augmented Reality Glasses and Noise-Cancelling Headphones to Reduce Dental Anxiety in Adult Patients (NA)
- Effects of Acupressure Applied to Intensive Care Patients on Physiological Parameters, Pain, Sleep Quality, Anxiety and Perception of Nursing Presence (NA)
- Essential Oil Inhalation and Acute Stress Response in Healthy Adults (NA)
- Functional Near-Infrared Spectroscopy and Virtual Reality Relaxation Programs for Pain Management in Patients With Cancer (NA)
- Nurse Led Interventions on Functional Trajectories, Sleep Quality, and Psychological Distress in Hemodialysis Patients (NA)
- Laser Therapy and Pelvic Floor Muscle Training for Stress Urinary Incontinence (NA)
- Multimodal Therapy for the Treatment of Fatigue in Patients With Prostate Cancer Receiving Radiotherapy With Androgen Deprivation Therapy (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placebo + relaxation CI brief — competitive landscape report
- Placebo + relaxation updates RSS · CI watch RSS
- University of Göttingen portfolio CI
Frequently asked questions about Placebo + relaxation
What is Placebo + relaxation?
How does Placebo + relaxation work?
What is Placebo + relaxation used for?
Who makes Placebo + relaxation?
What development phase is Placebo + relaxation in?
What are the side effects of Placebo + relaxation?
Related
- Manufacturer: University of Göttingen — full pipeline
- Therapeutic area: All drugs in Psychiatry/Psychology, Pain Management, Stress-related disorders
- Indication: Drugs for Stress-related conditions and anxiety (research/marketed context)
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing